UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.31% |
| 2 | Technology | 9.89% |
| 3 | Financials | 7.42% |
| 4 | Healthcare | 6.84% |
| 5 | Consumer Discretionary | 5.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5576
First Northwest Bancorp
FNWB
$95.6M
| $208K | ﹤0.01% |
11,476
+3,017
| +36% | +$52.9K |
|
5577
Moderna
MRNA
$79.4B
| $208K | ﹤0.01% |
10,609
-49,245
| -82% | -$874K |
|
5578
Ocular Therapeutix
OCUL
$2.12B
| $208K | ﹤0.01% |
52,695
+26,812
| +104% | +$93.2K |
|
|
CBL
5579
CALL
DELISTED
CBL& Associates Properties, Inc.
CBL
| $208K | ﹤0.01% |
198,200
| – | – |
|
|
ESTE
5580
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $208K | ﹤0.01% |
32,847
+11,641
| +55% | +$54.8K |
|
5581
American Superconductor
AMSC
$1.45B
| $207K | ﹤0.01% |
26,474
+10,660
| +67% | +$85.9K |
|
5582
Bassett Furniture
BSET
$158M
| $207K | ﹤0.01% |
12,405
+5,072
| +69% | +$78.7K |
|
|
CASI
5583
DELISTED
CASI Pharmaceuticals
CASI
| $207K | ﹤0.01% |
6,710
+2,554
| +61% | +$82.8K |
|
5584
CALL
Estee Lauder
EL
$34.2B
| $207K | ﹤0.01% |
1,000
| – | – |
|
|
MSD
5585
Morgan Stanley Emerging Markets Debt Fund
MSD
$142M
| $207K | ﹤0.01% |
21,423
-4,569
| -18% | -$43.2K |
|
5586
Noodles & Co
NDLS
$75.2M
| $207K | ﹤0.01% |
4,681
+1,476
| +46% | +$65.2K |
|
5587
Ohio Valley Banc Corp
OVBC
$208M
| $207K | ﹤0.01% |
5,228
+1,949
| +59% | +$73.1K |
|
5588
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.28B
| $207K | ﹤0.01% |
7,820
+1,357
| +21% | +$35.8K |
|
|
ESSA
5589
DELISTED
ESSA Bancorp
ESSA
| $206K | ﹤0.01% |
12,159
+4,032
| +50% | +$67.2K |
|
5590
Renaissance IPO ETF
IPO
$150M
| $206K | ﹤0.01% |
6,628
+3,720
| +128% | +$111K |
|
5591
Target Hospitality
TH
$2.02B
| $206K | ﹤0.01% |
41,148
+18,952
| +85% | +$99.7K |
|
|
TCRR
5592
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $206K | ﹤0.01% |
14,453
+5,481
| +61% | +$84.7K |
|
|
CHMA
5593
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $206K | ﹤0.01% |
41,578
+12,940
| +45% | +$67.4K |
|
5594
Stagwell
STGW
$2.03B
| $205K | ﹤0.01% |
73,692
+18,179
| +33% | +$49K |
|
5595
Donegal Group Class A
DGICA
$671M
| $204K | ﹤0.01% |
13,791
+4,473
| +48% | +$65.4K |
|
|
FT
5596
Franklin Universal Trust
FT
$178M
| $204K | ﹤0.01% |
26,246
| – | – |
|
5597
MainStreet Bancshares
MNSB
$177M
| $202K | ﹤0.01% |
8,773
+3,077
| +54% | +$67K |
|
|
FNCB
5598
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $202K | ﹤0.01% |
23,938
+9,720
| +68% | +$76.4K |
|
5599
BioLife Solutions
BLFS
$1.88B
| $201K | ﹤0.01% |
12,433
+6,226
| +100% | +$101K |
|
5600
ARK Israel Innovative Technology ETF
IZRL
$134M
| $201K | ﹤0.01% |
9,072
+608
| +7% | +$13.1K |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 807 new, 4,306 increased, 2,683 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 50% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 807 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.